- Accesswire•9 hours agoCould 2017 Prove to be a Bull Market for Biotechs? Today's Reports on Depomed and Amicus Therapeutics
NEW YORK, NY / ACCESSWIRE / February 23, 2017 / The Biotech Industry has posted some impressive gains since election result and the rally has continued for the larger part of this year. Both the iShares ...
- Investopedia•13 hours ago
Here's why one hedge fund manager is betting big on small-cap biotech firms.
- GlobeNewswire•yesterdayAmicus Therapeutics to Announce Full-Year 2016 Financial Results and Corporate Updates on March 1, 2017
CRANBURY, N.J., Feb. 22, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced a conference call and live audio webcast ...
FOLD : Summary for Amicus Therapeutics, Inc. - Yahoo Finance
Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||5.88 x 1500|
|Ask||6.08 x 1000|
|Day's Range||5.88 - 6.10|
|52 Week Range||4.41 - 9.83|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-4.27|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|